Carlsmed (CARL) Other Non-Current Liabilities (2024 - 2026)

Carlsmed (CARL) has reported Other Non-Current Liabilities for 3 consecutive years, with $345000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities fell 52.54% year-over-year to $345000.0; the trailing twelve-month figure through Jun 2026 stood at $345000.0 (down 52.54% YoY), and the FY2025 full-year result was $309000.0, down 32.39% from the prior year.
• Other Non-Current Liabilities grew to $345000.0 in Q2 2026 per CARL's latest filing, from $327000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $727000.0 in Q2 2025 and bottomed at $290000.0 in Q3 2025.
• Historically, Other Non-Current Liabilities has averaged $409166.7 across 3 years, with a median of $336000.0 in 2026.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities plunged 32.39% in 2025, then slumped 52.54% in 2026.
• Over 3 years, Other Non-Current Liabilities stood at $457000.0 in 2024, then slumped by 32.39% to $309000.0 in 2025, then increased by 11.65% to $345000.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $345000.0, $327000.0, and $309000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.